FIELD: biotechnology.
SUBSTANCE: two-chain ribonucleic acid (tcRNA) for AROS3 gene expression inhibition os described, where this tcRNA contains (a) a sense chain consisting of a nucleotide sequence GcuuAAAAGGGAcAGuAuudTsdT, and an antisense chain, consisting of a nucleotide sequence AAuACUGUCCCUUUuAAGCdTsdT; (b) a sense chain consisting of a nucleotide sequence GCUUAAAAGGGACAGUAUUdTsdT, and an antisense chain, consisting of a nucleotide sequence AAUACUGUCCCUUUUAAGCdTsdT, (c) a sense chain consisting of a nucleotide sequence GfcUfuAfaAfaGfgGfaCfaGfuAfuUfdTsdT, and an antisense chain, consisting of a nucleotide sequence aAfuAfcUfgUfcCfcUfuUfuAfaGfcdTsdT, or (d) a sense chain consisting of a nucleotide sequence of GcuuAAAAGGGAcAGuAuudTsdT, and an antisense chain, consisting of a nucleotide sequence AAuACuGUCCCuuuuAagcdTsdT, where nucleotidesdenoted by lowercase letters, are 2'-O-methyl nucleotides; Gf, Af, Uf and Cf are 2'-fluoro nucleotides; and s is a phosphorothioate bond. A pharmaceutical composition for APOC3 gene expression inhibition containing the said tcRNA is also described. Methods for APOC3 expression inhibiting in a cell and treatment of a disorder mediated by APOC3 expression, including application of the said tcRNA, are provided.
EFFECT: invention expands the arsenal of drugs designed to treat a disorder mediated by APOC3 expression.
12 cl, 4 dwg, 12 tbl, 7 ex
| Title |
Year |
Author |
Number |
| TREATMENT OF TUMORS OF DISEASES RELATED TO THE GENOM-SUPPRESSOR BY THERAPY OF NATURAL TRANSCRIPT INHIBITION IN ANTI-SIGNIFICANT ORIENTATION REGARDING THIS GENE |
2009 |
- Kollard Dzhozef
- Khorkova Sherman Olga
|
RU2618688C2 |
| TREATMENT OF TUMORS OF DISEASES RELATED TO THE GENOM-SUPPRESSOR BY THERAPY OF NATURAL TRANSCRIPT INHIBITION IN ANTI-SIGNIFICANT ORIENTATION REGARDING THIS GENE |
2009 |
- Kollard Dzhozef
- Khorkova Sherman Olga
|
RU2746478C2 |
| I-RNA COMPOSITIONS FOR SERPIN AND METHODS OF USE THEREOF |
2013 |
- Akink Akin
- Sekhgal Alfika
- Tudyarska Ivanka
- Foster Donald
- Milstejn Styuart
- Bettenkort Brajan
- Majer Martin
- Kharisse Klaus
- Kuchimanchi Satiyanarayana
- Radzhiv Kallantkhottatkhil G.
- Manokharan Mutkhiakh
|
RU2691580C2 |
| I-RNA COMPOSITIONS FOR SERPIN C1 AND METHODS OF USE THEREOF |
2013 |
- Akinc, Akin
- Sehgal, Alfica
- Toudjarska Ivanka
- Foster, Donald
- Milstein, Stuart
- Bettencourt, Brian
- Maier, Martin
- Charisse, Klaus
- Kuchimanchi, Satyanarayana
- Rajeev, Kallanthottathil, G.
- Manoharan, Muthiah
|
RU2832033C2 |
| MRNA COMPOSITION FOR PROTEIN SIMILAR TO ANGIOPOIETIN 3 (ANGPTL3) AND METHODS FOR USE THEREOF |
2012 |
- Bettenkort Brajan
- Kuerbs Uillyam
- Fittszherald Kevin
- Frank-Kamenetski Mariya
- Milstejn Styuart
- Shulga-Morskaya Svetlana
|
RU2711799C2 |
| CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID MOLECULES THAT MEDIATE RNA INTERFERENCE |
2006 |
- Morrisi Dehvid
- Maksvidzhen Dzhejms
- Bejdzhelman Leonid
|
RU2418068C2 |
| TREATMENT OF DISEASES CONNECTED WITH SITE-1 MEMBRANE-IMPACTED PEPTIDASE OF TRANSCRIPTION FACTORS (MBTPS1), BY INHIBITING NATURAL ANTISENSE TRANSCRIPT TO MBTPS1 |
2010 |
- Kollard Dzhozef
- Khorkova Sherman Olga
|
RU2639550C2 |
| TREATMENT OF DISEASES ASSOCIATED WITH ERYTHROPOIETIN (EPO) BY NATURAL EPO ANTISENSE TRANSCRIPT INHIBITION |
2009 |
- Kollard Dzhozef
- Khorkova Sherman Olga
|
RU2620970C2 |
| 11 BETA-HYDROXYSTEROID DEHYDROGENASE 1 EXPRESSION MODULATION FOR TREATING EYE DISEASES |
2006 |
- Khimenes Anton Ana Izabel'
- Jage Ankhela Sesto
- Khimenes Gomes Ma Konseps'On
|
RU2420582C2 |
| COMPOSITIONS AND METHODS FOR INHIBITING TMPRSS6 GENE EXPRESSION |
2012 |
- Bumkrot Devid
- Bettenkort Brajan
- Tudyarska Ivanka
|
RU2702501C2 |
